- Home
- KO vs NVS Comparison
KO vs NVS Comparison
Compare KO & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KO
- NVS
- Stock Information
- Founded
- KO 1886
- NVS 1895
- Country
- KO United States
- NVS Switzerland
- Employees
- KO N/A
- NVS N/A
- Industry
- KO Beverages (Production/Distribution)
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- KO Consumer Staples
- NVS Health Care
- Exchange
- KO Nasdaq
- NVS Nasdaq
- Market Cap
- KO 301.8B
- NVS 242.8B
- IPO Year
- KO 1919
- NVS 1991
- Fundamental
- Price
- KO $69.01
- NVS $128.23
- Analyst Decision
- KO Strong Buy
- NVS Hold
- Analyst Count
- KO 14
- NVS 5
- Target Price
- KO $77.00
- NVS $123.67
- AVG Volume (30 Days)
- KO 14.4M
- NVS 1.2M
- Earning Date
- KO 10-22-2025
- NVS 10-28-2025
- Dividend Yield
- KO 2.96%
- NVS 2.02%
- EPS Growth
- KO 14.64
- NVS N/A
- EPS
- KO 2.82
- NVS 6.85
- Revenue
- KO $47,062,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- KO $6.11
- NVS $9.01
- Revenue Next Year
- KO $5.74
- NVS $2.49
- P/E Ratio
- KO $24.47
- NVS $18.73
- Revenue Growth
- KO 1.28
- NVS 12.95
- 52 Week Low
- KO $60.62
- NVS $96.06
- 52 Week High
- KO $74.38
- NVS $128.44
- Technical
- Relative Strength Index (RSI)
- KO 45.80
- NVS 67.76
- Support Level
- KO $68.28
- NVS $125.66
- Resistance Level
- KO $69.34
- NVS $126.94
- Average True Range (ATR)
- KO 0.96
- NVS 1.19
- MACD
- KO -0.10
- NVS 0.24
- Stochastic Oscillator
- KO 37.67
- NVS 97.28
About KO Coca-Cola Company (The)
Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.